XW043B3
Introduction of Cytarabine and Daunorubicin Liposome Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 3
The ICD-10-PCS code for introduction of cytarabine and daunorubicin liposome antineoplastic into central vein, percutaneous approach, new technology group 3 is XW043B3.
New Technology · Anatomical Regions
Character breakdown
X
Section
W
Body System
0
Operation
4
Body Part
3
Approach
B
Device
3
Qualifier